126 related articles for article (PubMed ID: 3013344)
1. Natural history of primary infection with LAV in multitransfused patients. By the AIDS-Hemophilia French Study Group.
Blood; 1986 Jul; 68(1):89-94. PubMed ID: 3013344
[TBL] [Abstract][Full Text] [Related]
2. Immunologic and virologic status of multitransfused patients: role of type and origin of blood products. By the AIDS-Hemophilia French Study Group.
Blood; 1985 Oct; 66(4):896-901. PubMed ID: 2994780
[TBL] [Abstract][Full Text] [Related]
3. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
[TBL] [Abstract][Full Text] [Related]
4. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
Abe T
AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses.
Stein SF; Evatt BL; McDougal JS; Lawrence DN; Holman RC; Ramsey RB; Spira TJ
Blood; 1985 Oct; 66(4):973-9. PubMed ID: 2994784
[TBL] [Abstract][Full Text] [Related]
6. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
[TBL] [Abstract][Full Text] [Related]
7. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of lymphocyte subsets and anti-LAV/HTLV-III status in Greek hemophiliacs.
Choremi H; Economidou J; Psarra K; Sidiri E; Mandalaki T; Louizou C; Gialeraki A; Markakis C; Papaevangelou C; Kallinicos G
AIDS Res; 1986; 2(4):271-7. PubMed ID: 3101712
[TBL] [Abstract][Full Text] [Related]
9. Australian hemophiliac recipients of voluntary donor blood products longitudinally evaluated for AIDS. A clinical and laboratory study, 1983-1986.
Garsia RJ; Gatenby PA; Basten A; Kenny DF; Gallagher KJ; Rickard KA; Gust ID; Maskill W
Aust N Z J Med; 1987 Aug; 17(4):371-8. PubMed ID: 2963611
[TBL] [Abstract][Full Text] [Related]
10. HTLV III antibodies and immunological alterations in hemophilia patients.
Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to acquired immune deficiency syndrome (AIDS)-associated virus (HTLV-III/LAV) in Venezuelan populations.
Volsky DJ; Rodriguez L; Dewhurst S; Sinangil F; Sakai K; Merino F; Esparza B; De Salvo L
AIDS Res; 1986; 2(2):79-92. PubMed ID: 3013223
[TBL] [Abstract][Full Text] [Related]
12. HTLV-III/LAV antibody status of spouses and household contacts assisting in home infusion of hemophilia patients.
Lawrence DN; Jason JM; Bouhasin JD; McDougal JS; Knutsen AP; Evatt BL; Joist JH
Blood; 1985 Sep; 66(3):703-5. PubMed ID: 2992640
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
[TBL] [Abstract][Full Text] [Related]
14. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.
Fultz PN; McClure HM; Swenson RB; McGrath CR; Brodie A; Getchell JP; Jensen FC; Anderson DC; Broderson JR; Francis DP
J Virol; 1986 Apr; 58(1):116-24. PubMed ID: 3005641
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of HTLV-III infection in a hemophilic cohort treated with blood products from a single manufacturer.
McGrath KM; Spelman D; Barnett M; Kellner S
Am J Hematol; 1986 Nov; 23(3):239-45. PubMed ID: 3020977
[TBL] [Abstract][Full Text] [Related]
16. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies].
Aymard JP; Janot C; Briquel ME; André E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F
Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiology of infection by LAV/HTLV-III virus in hemophiliacs multitransfused in France. Results of a survey conducted by 28 hemophilia centers].
Sultan Y
Nouv Rev Fr Hematol (1978); 1986; 28(5):327-9. PubMed ID: 3643509
[TBL] [Abstract][Full Text] [Related]
18. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States.
Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ
Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787
[TBL] [Abstract][Full Text] [Related]
19. HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.
Volsky DJ; Wu YT; Sinangil F; Goldsmith JC
AIDS Res; 1986 Feb; 2(1):51-61. PubMed ID: 2424467
[TBL] [Abstract][Full Text] [Related]
20. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome.
Sundqvist VA; Linde A; Kurth R; Werner A; Helm EB; Popovic M; Gallo RC; Wahren B
J Infect Dis; 1986 May; 153(5):970-3. PubMed ID: 3009638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
